摘要
目的：为临床合理、安全应用抗心律失常药提供参考。方法：收集2002-2005年我国抗心律失常药应用数据，并进行对比分析。结果：抗心律失常药销售金额呈逐年上升趋势，用药频度排序前5位药品各年基本相同，包括普罗帕酮、胺碘酮、美西律、莫雷西嗪和阿普林定。结论：我国抗心律失常药应用较为合理；新的Ⅲ类抗心律失常药的应用有增长趋势。
OBJECTIVE： To evaluate the current situation and trends of antiarrhythmic drug use in China and provide references for rational, efficient and economical use of antiarrhythmic drugs in clinic. METHODS： The sales volume, sales amount of antiarrhythmic drugs from 2002 to 2005 in China were investigated and analyzed. RESULTS： The drugs that dominated the first 5 places were almost the same in 4 years, i.e. propafenone, amiodarone, mexiletine, moricizine and aprindine. CONCLUSION： The clinical application of antiarrhythmic drugs in China was rational and Class Ⅲ antiarrhythmic drugs will be more and more popular.
出处
《中国药房》
CAS
CSCD
北大核心
2007年第1期19-21,共3页
China Pharmacy
